James McGrath

The cutting-edge tool demonstrates how the blood-brain barrier breaks down and how healthy brains keep it strong.

The method uses ultrathin membranes to capture tiny packets of cellular material called extracellular vesicles.

Researchers will use tissue-on-chip technology as a new way to explore the relationship between the lungs and brain.

Rochester is one of four NIH-sponsored centers that aims to produce tissue-on-chip devices as FDA-qualified drug development tools.

The biomedical engineering professor’s approach has spillover effects beyond the signature undergraduate course he’s taught for 20 years.

Extracellular vesicles could provide early detection of diseases such as cancer. But to analyze EVs, scientists first need to catch them. That’s where Rochester professor James McGrath’s nanomembranes come in.

Detecting tiny biomarkers circulating in our bodies is problematic and costly. Researchers are developing a cost-effective detection device using nanotechnology.

A multidisciplinary collaboration will create a new light-sheet microscope on campus, allowing 3D imaging of complex cellular structures.

Rochester researchers are building technology to predict the course of tendon injuries—a form of personalized medicine that will lead to more effective treatments.

Nanomembranes, optical sensors, and blood analysis: Rochester faculty are turning previous research avenues to focus on ways to quickly detect novel coronavirus to speed treatment.